 | • レポートコード：QYR2104Z2267 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、発疹のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非抗生物質）、用途別市場規模（ルベオラ、風疹、伝染性紅斑、突発性発疹）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・発疹の市場動向 ・企業の競争状況、市場シェア ・発疹の種類別市場規模（抗生物質、非抗生物質） ・発疹の用途別市場規模（ルベオラ、風疹、伝染性紅斑、突発性発疹） ・発疹の北米市場規模2016-2027（アメリカ、カナダ） ・発疹のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・発疹のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・発疹の中南米市場規模2016-2027（メキシコ、ブラジル） ・発疹の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Manus Aktteva Biopharma、Teva Pharmaceutical Industries、CIRON Drugs & Pharmaceuticals、Iol Chemicals and Pharmaceuticals、Mikart、Ranbaxy Laboratories、Hikma、Nexgen Pharma） ・結論 |
An exanthem or exanthema is a widespread rash usually occurring in children. An exanthem can be caused by toxins, drugs, or microorganisms, or can result from autoimmune disease.
Geographically, North America dominated the exanthema market and Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness levels, modernizing healthcare infrastructure and favourable government support in this region.
Market Analysis and Insights: Global Exanthema Market
The global Exanthema market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exanthema market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exanthema market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exanthema market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exanthema market.
Global Exanthema Scope and Market Size
Exanthema market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exanthema market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotic Drugs
Non-antibiotic Drugs
Segment by Application
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Manus Aktteva Biopharma
Teva Pharmaceutical Industries
CIRON Drugs & Pharmaceuticals
Iol Chemicals and Pharmaceuticals
Mikart
Ranbaxy Laboratories
Hikma
Nexgen Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exanthema Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotic Drugs
1.2.3 Non-antibiotic Drugs
1.3 Market by Application
1.3.1 Global Exanthema Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rubeola
1.3.3 Rubella
1.3.4 Erythema Infectiosum
1.3.5 Roseola Infantum
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exanthema Market Perspective (2016-2027)
2.2 Exanthema Growth Trends by Regions
2.2.1 Exanthema Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exanthema Historic Market Share by Regions (2016-2021)
2.2.3 Exanthema Forecasted Market Size by Regions (2022-2027)
2.3 Exanthema Industry Dynamic
2.3.1 Exanthema Market Trends
2.3.2 Exanthema Market Drivers
2.3.3 Exanthema Market Challenges
2.3.4 Exanthema Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exanthema Players by Revenue
3.1.1 Global Top Exanthema Players by Revenue (2016-2021)
3.1.2 Global Exanthema Revenue Market Share by Players (2016-2021)
3.2 Global Exanthema Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exanthema Revenue
3.4 Global Exanthema Market Concentration Ratio
3.4.1 Global Exanthema Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exanthema Revenue in 2020
3.5 Exanthema Key Players Head office and Area Served
3.6 Key Players Exanthema Product Solution and Service
3.7 Date of Enter into Exanthema Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exanthema Breakdown Data by Type
4.1 Global Exanthema Historic Market Size by Type (2016-2021)
4.2 Global Exanthema Forecasted Market Size by Type (2022-2027)
5 Exanthema Breakdown Data by Application
5.1 Global Exanthema Historic Market Size by Application (2016-2021)
5.2 Global Exanthema Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Exanthema Market Size (2016-2027)
6.2 North America Exanthema Market Size by Type
6.2.1 North America Exanthema Market Size by Type (2016-2021)
6.2.2 North America Exanthema Market Size by Type (2022-2027)
6.2.3 North America Exanthema Market Size by Type (2016-2027)
6.3 North America Exanthema Market Size by Application
6.3.1 North America Exanthema Market Size by Application (2016-2021)
6.3.2 North America Exanthema Market Size by Application (2022-2027)
6.3.3 North America Exanthema Market Size by Application (2016-2027)
6.4 North America Exanthema Market Size by Country
6.4.1 North America Exanthema Market Size by Country (2016-2021)
6.4.2 North America Exanthema Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Exanthema Market Size (2016-2027)
7.2 Europe Exanthema Market Size by Type
7.2.1 Europe Exanthema Market Size by Type (2016-2021)
7.2.2 Europe Exanthema Market Size by Type (2022-2027)
7.2.3 Europe Exanthema Market Size by Type (2016-2027)
7.3 Europe Exanthema Market Size by Application
7.3.1 Europe Exanthema Market Size by Application (2016-2021)
7.3.2 Europe Exanthema Market Size by Application (2022-2027)
7.3.3 Europe Exanthema Market Size by Application (2016-2027)
7.4 Europe Exanthema Market Size by Country
7.4.1 Europe Exanthema Market Size by Country (2016-2021)
7.4.2 Europe Exanthema Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Exanthema Market Size (2016-2027)
8.2 Asia-Pacific Exanthema Market Size by Type
8.2.1 Asia-Pacific Exanthema Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exanthema Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exanthema Market Size by Type (2016-2027)
8.3 Asia-Pacific Exanthema Market Size by Application
8.3.1 Asia-Pacific Exanthema Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exanthema Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exanthema Market Size by Application (2016-2027)
8.4 Asia-Pacific Exanthema Market Size by Region
8.4.1 Asia-Pacific Exanthema Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exanthema Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exanthema Market Size (2016-2027)
9.2 Latin America Exanthema Market Size by Type
9.2.1 Latin America Exanthema Market Size by Type (2016-2021)
9.2.2 Latin America Exanthema Market Size by Type (2022-2027)
9.2.3 Latin America Exanthema Market Size by Type (2016-2027)
9.3 Latin America Exanthema Market Size by Application
9.3.1 Latin America Exanthema Market Size by Application (2016-2021)
9.3.2 Latin America Exanthema Market Size by Application (2022-2027)
9.3.3 Latin America Exanthema Market Size by Application (2016-2027)
9.4 Latin America Exanthema Market Size by Country
9.4.1 Latin America Exanthema Market Size by Country (2016-2021)
9.4.2 Latin America Exanthema Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exanthema Market Size (2016-2027)
10.2 Middle East & Africa Exanthema Market Size by Type
10.2.1 Middle East & Africa Exanthema Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exanthema Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exanthema Market Size by Type (2016-2027)
10.3 Middle East & Africa Exanthema Market Size by Application
10.3.1 Middle East & Africa Exanthema Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exanthema Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exanthema Market Size by Application (2016-2027)
10.4 Middle East & Africa Exanthema Market Size by Country
10.4.1 Middle East & Africa Exanthema Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exanthema Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Manus Aktteva Biopharma
11.1.1 Manus Aktteva Biopharma Company Details
11.1.2 Manus Aktteva Biopharma Business Overview
11.1.3 Manus Aktteva Biopharma Exanthema Introduction
11.1.4 Manus Aktteva Biopharma Revenue in Exanthema Business (2016-2021)
11.1.5 Manus Aktteva Biopharma Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Exanthema Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Exanthema Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 CIRON Drugs & Pharmaceuticals
11.3.1 CIRON Drugs & Pharmaceuticals Company Details
11.3.2 CIRON Drugs & Pharmaceuticals Business Overview
11.3.3 CIRON Drugs & Pharmaceuticals Exanthema Introduction
11.3.4 CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2016-2021)
11.3.5 CIRON Drugs & Pharmaceuticals Recent Development
11.4 Iol Chemicals and Pharmaceuticals
11.4.1 Iol Chemicals and Pharmaceuticals Company Details
11.4.2 Iol Chemicals and Pharmaceuticals Business Overview
11.4.3 Iol Chemicals and Pharmaceuticals Exanthema Introduction
11.4.4 Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2016-2021)
11.4.5 Iol Chemicals and Pharmaceuticals Recent Development
11.5 Mikart
11.5.1 Mikart Company Details
11.5.2 Mikart Business Overview
11.5.3 Mikart Exanthema Introduction
11.5.4 Mikart Revenue in Exanthema Business (2016-2021)
11.5.5 Mikart Recent Development
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Company Details
11.6.2 Ranbaxy Laboratories Business Overview
11.6.3 Ranbaxy Laboratories Exanthema Introduction
11.6.4 Ranbaxy Laboratories Revenue in Exanthema Business (2016-2021)
11.6.5 Ranbaxy Laboratories Recent Development
11.7 Hikma
11.7.1 Hikma Company Details
11.7.2 Hikma Business Overview
11.7.3 Hikma Exanthema Introduction
11.7.4 Hikma Revenue in Exanthema Business (2016-2021)
11.7.5 Hikma Recent Development
11.8 Nexgen Pharma
11.8.1 Nexgen Pharma Company Details
11.8.2 Nexgen Pharma Business Overview
11.8.3 Nexgen Pharma Exanthema Introduction
11.8.4 Nexgen Pharma Revenue in Exanthema Business (2016-2021)
11.8.5 Nexgen Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Exanthema Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotic Drugs
Table 3. Key Players of Non-antibiotic Drugs
Table 4. Global Exanthema Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Exanthema Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exanthema Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Exanthema Market Share by Regions (2016-2021)
Table 8. Global Exanthema Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Exanthema Market Share by Regions (2022-2027)
Table 10. Exanthema Market Trends
Table 11. Exanthema Market Drivers
Table 12. Exanthema Market Challenges
Table 13. Exanthema Market Restraints
Table 14. Global Exanthema Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Exanthema Market Share by Players (2016-2021)
Table 16. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2020)
Table 17. Ranking of Global Top Exanthema Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Exanthema Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exanthema Product Solution and Service
Table 21. Date of Enter into Exanthema Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Exanthema Revenue Market Share by Type (2016-2021)
Table 25. Global Exanthema Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Exanthema Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Exanthema Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Exanthema Revenue Market Share by Application (2016-2021)
Table 29. Global Exanthema Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Exanthema Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Exanthema Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Exanthema Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Exanthema Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Exanthema Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Exanthema Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Exanthema Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Exanthema Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Exanthema Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Exanthema Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Exanthema Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Exanthema Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Exanthema Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Exanthema Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Exanthema Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Exanthema Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Exanthema Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Exanthema Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Exanthema Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Exanthema Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Exanthema Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Exanthema Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Exanthema Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Exanthema Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Exanthema Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Exanthema Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Exanthema Market Size by Country (2022-2027) & (US$ Million)
Table 61. Manus Aktteva Biopharma Company Details
Table 62. Manus Aktteva Biopharma Business Overview
Table 63. Manus Aktteva Biopharma Exanthema Product
Table 64. Manus Aktteva Biopharma Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 65. Manus Aktteva Biopharma Recent Development
Table 66. Teva Pharmaceutical Industries Company Details
Table 67. Teva Pharmaceutical Industries Business Overview
Table 68. Teva Pharmaceutical Industries Exanthema Product
Table 69. Teva Pharmaceutical Industries Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 70. Teva Pharmaceutical Industries Recent Development
Table 71. CIRON Drugs & Pharmaceuticals Company Details
Table 72. CIRON Drugs & Pharmaceuticals Business Overview
Table 73. CIRON Drugs & Pharmaceuticals Exanthema Product
Table 74. CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 75. CIRON Drugs & Pharmaceuticals Recent Development
Table 76. Iol Chemicals and Pharmaceuticals Company Details
Table 77. Iol Chemicals and Pharmaceuticals Business Overview
Table 78. Iol Chemicals and Pharmaceuticals Exanthema Product
Table 79. Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 80. Iol Chemicals and Pharmaceuticals Recent Development
Table 81. Mikart Company Details
Table 82. Mikart Business Overview
Table 83. Mikart Exanthema Product
Table 84. Mikart Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 85. Mikart Recent Development
Table 86. Ranbaxy Laboratories Company Details
Table 87. Ranbaxy Laboratories Business Overview
Table 88. Ranbaxy Laboratories Exanthema Product
Table 89. Ranbaxy Laboratories Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 90. Ranbaxy Laboratories Recent Development
Table 91. Hikma Company Details
Table 92. Hikma Business Overview
Table 93. Hikma Exanthema Product
Table 94. Hikma Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 95. Hikma Recent Development
Table 96. Nexgen Pharma Company Details
Table 97. Nexgen Pharma Business Overview
Table 98. Nexgen Pharma Revenue in Exanthema Business (2016-2021) & (US$ Million)
Table 99. Nexgen Pharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exanthema Market Share by Type: 2020 VS 2027
Figure 2. Antibiotic Drugs Features
Figure 3. Non-antibiotic Drugs Features
Figure 4. Global Exanthema Market Share by Application: 2020 VS 2027
Figure 5. Rubeola Case Studies
Figure 6. Rubella Case Studies
Figure 7. Erythema Infectiosum Case Studies
Figure 8. Roseola Infantum Case Studies
Figure 9. Exanthema Report Years Considered
Figure 10. Global Exanthema Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Exanthema Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Exanthema Market Share by Regions: 2020 VS 2027
Figure 13. Global Exanthema Market Share by Regions (2022-2027)
Figure 14. Global Exanthema Market Share by Players in 2020
Figure 15. Global Top Exanthema Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exanthema as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Exanthema Revenue in 2020
Figure 17. Global Exanthema Revenue Market Share by Type (2016-2021)
Figure 18. Global Exanthema Revenue Market Share by Type (2022-2027)
Figure 19. North America Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Exanthema Market Share by Type (2016-2027)
Figure 21. North America Exanthema Market Share by Application (2016-2027)
Figure 22. North America Exanthema Market Share by Country (2016-2027)
Figure 23. United States Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Exanthema Market Share by Type (2016-2027)
Figure 27. Europe Exanthema Market Share by Application (2016-2027)
Figure 28. Europe Exanthema Market Share by Country (2016-2027)
Figure 29. Germany Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Exanthema Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Exanthema Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Exanthema Market Share by Region (2016-2027)
Figure 39. China Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Exanthema Market Share by Type (2016-2027)
Figure 47. Latin America Exanthema Market Share by Application (2016-2027)
Figure 48. Latin America Exanthema Market Share by Country (2016-2027)
Figure 49. Mexico Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Exanthema Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Exanthema Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Exanthema Market Share by Country (2016-2027)
Figure 55. Turkey Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Exanthema Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Manus Aktteva Biopharma Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 59. Teva Pharmaceutical Industries Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 60. CIRON Drugs & Pharmaceuticals Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 61. Iol Chemicals and Pharmaceuticals Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 62. Mikart Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 63. Ranbaxy Laboratories Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 64. Hikma Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 65. Nexgen Pharma Revenue Growth Rate in Exanthema Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の鼻血治療薬市場規模・現状・予測（2021年-2027年） A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils. Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to c…- 世界の鼻血治療薬市場規模・現状・予測（2021年-2027年） A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils. Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to c…
- 世界のドライアイ治療薬・治療用装置市場規模・現状・予測（2021年-2027年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 世界のイロプロスト薬市場規模・現状・予測（2021年-2027年） Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. North America is estimated to have a major share in the global market with 75%. Market Analysis…
- 世界の家禽用抗生物質市場 2021：企業別、地域別、種類・用途別 The Poultry Antibiotic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…